Pivotal Therapeutics
Woodbridge
About Pivotal Therapeutics
Pivotal Therapeutics Inc. is a specialty pharmaceutical company with a focus on optimizing Omega-3 therapy for cardiovascular disease and overall health. Pivotal developed its lead product VASCAZEN® based on the scientific evidence on the benefits of Omega-3 for cardiovascular patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $6.9M
- Funding stage: IPO
- Last round: Post-IPO Debt (Mar 2014)
- Ticker: otcpink:PVTTF
- Website: pivotaltherapeutics.us
- Phone: +1 905-856-9797
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/pivotal-therapeutics-3501932 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.